Registry of lecanemab treatment for Alzheimer's in Canada

This study looks at people who are taking or have taken lecanemab (a medication for Alzheimer's disease). It aims to gather more information about the treatment's effects in real-world settings.

This study tracks the real-world experience of people with early Alzheimer's disease who are already taking lecanemab. It aims to better understand how the medication works and its safety in everyday medical practice.

This study looks at the long-term effects of the Alzheimer's drug LEQEMBI (lecanemab) in people with mild memory problems or early Alzheimer's. It gathers information from patients who have already been taking the drug for 18 months to see how they are doing.

This study tracks the safety of Leqembi (lecanemab), a treatment for Alzheimer's disease, in people who are already prescribed it in the UK. It helps doctors learn more about how the medicine affects patients in everyday life.

This study tests a new treatment, called X/T, for people with Alzheimer's disease who are already taking lecanemab (Leqembi). The goal is to see if adding X/T is safe and tolerable, and if it might help manage symptoms.

This study observes people with Alzheimer's disease who are taking leqembi in Taiwan to learn more about how it works in everyday use. It may help understand the treatment's benefits and risks outside of clinical trials.